Muhammad, A.M.; Zari, A.; Alsubhi, N.H.; Al-Zahrani, M.H.; Alghamdi, R.A.; Labib, M.M.
Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach. Molecules 2022, 27, 4518.
https://doi.org/10.3390/molecules27144518
AMA Style
Muhammad AM, Zari A, Alsubhi NH, Al-Zahrani MH, Alghamdi RA, Labib MM.
Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach. Molecules. 2022; 27(14):4518.
https://doi.org/10.3390/molecules27144518
Chicago/Turabian Style
Muhammad, Ashraf M., Ali Zari, Nouf H. Alsubhi, Maryam H. Al-Zahrani, Rana Abdullah Alghamdi, and Mai M. Labib.
2022. "Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach" Molecules 27, no. 14: 4518.
https://doi.org/10.3390/molecules27144518
APA Style
Muhammad, A. M., Zari, A., Alsubhi, N. H., Al-Zahrani, M. H., Alghamdi, R. A., & Labib, M. M.
(2022). Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach. Molecules, 27(14), 4518.
https://doi.org/10.3390/molecules27144518
